Compositions and methods for treating pancreatic cancer
First Claim
Patent Images
1. A method for treating pancreatic cancer in a human subject in need thereof, comprising:
- (i) selecting a subject diagnosed with stage III or stage IV pancreatic cancer;
(ii) sensitizing a pancreatic tumor to a chemotherapeutic agent comprising, administering to the subject an effective amount of Trabedersen for at least one cycle prior to administration of the chemotherapeutic agent; and
(iii) subsequently administering an effective amount of the chemotherapeutic agent to the subject,wherein the chemotherapeutic agent is paclitaxel, dacarbazine or a combination thereof, and wherein the cycle consists of administering Trabedersen for 4 days and not administering Trabedersen for 10 days,so as to treat pancreatic cancer in the subject.
1 Assignment
0 Petitions
Accused Products
Abstract
Provided herein are composition for sensitizing tumors to anti-tumor therapies. The compositions include antisense oligonucleotides against TGFβ2, wherein the compositions sensitize tumors to anti-tumor therapies. Also provided herein are method for treating cancer using the compositions described herein.
58 Citations
11 Claims
-
1. A method for treating pancreatic cancer in a human subject in need thereof, comprising:
-
(i) selecting a subject diagnosed with stage III or stage IV pancreatic cancer; (ii) sensitizing a pancreatic tumor to a chemotherapeutic agent comprising, administering to the subject an effective amount of Trabedersen for at least one cycle prior to administration of the chemotherapeutic agent; and (iii) subsequently administering an effective amount of the chemotherapeutic agent to the subject, wherein the chemotherapeutic agent is paclitaxel, dacarbazine or a combination thereof, and wherein the cycle consists of administering Trabedersen for 4 days and not administering Trabedersen for 10 days, so as to treat pancreatic cancer in the subject. - View Dependent Claims (2, 3, 4, 5)
-
-
6. A method for treating, inhibiting, reducing the severity of and/or preventing metastasis of pancreatic cancer in a subject in need thereof, comprising:
-
(i) sensitizing a pancreatic tumor to a chemotherapeutic agent comprising, administering to the subject an effective amount of Trabedersen prior to administration of the chemotherapeutic agent; and (ii) subsequently administering an effective amount of the chemotherapeutic agent to the subject, wherein the subject is human and has been diagnosed with stage III or stage IV pancreatic cancer, so as to treat, inhibit, reduce severity of and/or prevent metastasis of pancreatic cancer in the subject. - View Dependent Claims (7, 8, 9, 10, 11)
-
Specification